Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease
Clinical trial NCT01731691 · TERMINATED
Trial details
- NCT number
- NCT01731691
- Sponsor
- Institute for Human Genetics and Biochemistry
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2014-07-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.